Package 70518-0133-1

{"route": ["ORAL"], "spl_id": "47e34555-87fd-5424-e063-6294a90a7fa0", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313413"], "spl_set_id": ["59084f59-9a9b-49f0-a9f4-27f3eab9a228"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (70518-0133-0)", "package_ndc": "70518-0133-0", "marketing_start_date": "20170107"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (70518-0133-1)", "package_ndc": "70518-0133-1", "marketing_start_date": "20170405"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (70518-0133-3)", "package_ndc": "70518-0133-3", "marketing_start_date": "20210107"}], "brand_name": "Tizanidine", "product_id": "70518-0133_47e34555-87fd-5424-e063-6294a90a7fa0", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "70518-0133", "generic_name": "Tizanidine", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA076286", "marketing_category": "ANDA", "marketing_start_date": "20170107", "listing_expiration_date": "20271231"}